A meta-analysis of 13 randomized controlled trials found no association between
dipeptidyl peptidase-4 inhibitor use and inflammatory bowel disease risk in patients with type 2 diabetes.
Association holds when considering only those most recently diagnosed, Caucasians.
Researchers conducted a retrospective study of pediatric patients with inflammatory bowel disease to estimate the risk for cancer and mortality associated with this diagnosis.
Risk lasts through 40 years of adulthood for underweight adolescent men.
CalproQuest survey may increase pretest probability for a positive calprotectin test.
The American Gastroenterological Association has published a report, Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway.
Increased risk for new-onset, postpartum mental illness observed in patients with inflammatory bowel disease.
Item-reduced version with 8 questions instead of 28 accounted for 77% of variance.
Psoriasis appears to be significantly associated with inflammatory bowel disease.
Heavy use in Crohn’s, heavy or moderate use in ulcerative colitis tied to increased risk of death
